Altimmune

Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
Motley Fool
Sun, 06/30/24 - 09:56 pm
Altimmune
Novo Nordisk
Wegovy
weight loss
pemvidutide
Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass
BioSpace
Mon, 06/24/24 - 10:18 pm
Altimmune
pemvidutide
weight loss
clinical trials
obesity
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Mon, 04/15/24 - 11:24 am
MASH
NASH
Madrigal Pharmaceuticals
Rezdiffra
Ionis Pharmaceuticals
ION224
Altimmune
pemvidutid
89Bio
pegozafermin
Viking Therapeutics
VK2809
Aligos Therapeutics
ALG-055009
Altimmune bails on hepatitis B after phase 2 data disappoint, quashing partnering plans
Fierce Biotech
Wed, 03/27/24 - 10:38 pm
Altimmune
hepatitis B
clinical trials
HepTcell
Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News
BioSpace
Fri, 12/1/23 - 09:46 am
Altimmune
clinical trials
obesity
GLP-1 agonist
pemvidutide
Altimmune completes dosing in MOMENTUM trial to treat obesity
Clinical Trials Arena
Wed, 09/13/23 - 11:15 am
Altimmune
clinical trials
pemvidutide
obesity
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
obesity
clinical trials
Novo Nordisk
Altimmune
Innovent Biologics
Pfizer
Shionogi
Tonix
semaglutide
oxytocin
permvidutide
mazdutide
danuglipron
Altimmune's obesity drug throws up safety concerns, shares plunge
Yahoo/Reuters
Tue, 03/21/23 - 10:10 am
Altimmune
obesity
clinical trials
Altimmune aims to build Momentum in obesity
EP Vantage
Thu, 03/2/23 - 09:55 am
Altimmune
incretin pemvidutide
obesity
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist
Fierce Biotech
Wed, 09/14/22 - 08:06 pm
Altimmune
NASH
clinical trials
pemvidutide
Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy
Seeking Alpha
Tue, 09/28/21 - 11:14 pm
Altimmune
clinical trials
obesity
pemvidutide
Combining forces in metabolic disorders
EP Vantage
Mon, 06/28/21 - 10:45 am
Altimmune
obesity
clinical trials
metabolic disorders
Altimmune's Covid Vaccine Candidate Placed on Clinical Hold
TheStreet.com
Sat, 12/26/20 - 08:23 pm
Altimmune
AdCOVID
vaccines
FDA
clinical trials
clinical hold
The long path to an effective coronavirus vaccine
EP Vantage
Fri, 04/3/20 - 06:31 pm
vaccines
COVID-19
coronaviruses
Moderna Therapeutics
Shenzhen Genoimmune
Cansino Biologics
Pfizer
BioNTech
Inovio
JNJ
Altimmune
Heat Biologics
iBio
EpiVax
Altimmune's Flu Shot Study: What You Need To Know
Yahoo/Benzinga
Wed, 03/20/19 - 10:00 am
Altimmune
NasoVax
vaccines
flu vaccines
clinical trials
Altimmune Raises $25 million With Direct Offering
CP WIre
Mon, 10/8/18 - 10:56 pm
Altimmune
Altimmune Raises $25 million With Direct Offering
Mon, 10/8/18 - 10:46 am
Altimmune